USPTO serial 79310327
BELTEST-IT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2022
- Examiner
- LOOK, JEFFREY J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BELTEST-IT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DE
DE
CH
CH
CH
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Gregg
Brian P. Gregg MCNEES WALLACE & NURICK100 PINE STREETHARRISBURG, PA 17108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | In-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical diagnosis, namely, biological indicators for monitoring sterilization processes for medical purposes; diagnostic chemical reagents for medical use; reactants for medical diagnosis; diagnostic preparations for medical or veterinary purposes; cotton wool in the form of sticks for medical use; chemical reagents for veterinary use; cellulose wadding for medical purposes; diagnostic substances for medical use; reagents for use in analysis for veterinary purposes; enzymes for medical purposes; reagents for analytical purposes for veterinary purposes; tampons for medical purposes; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic testing materials, namely, chemical preparations, chemical reagents, test strips, biological indicators for medical use; enzyme preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for medical purposes, namely, chemical preparations for medical and veterinary diagnostic purposes; chemical preparations for medical purposes for the treatment of treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; cellulose wool for medical use; reagents for analytical purposes for medical purposes; chemical reagents for medical use; enzyme preparations for veterinary purposes; reagent paper for medical or veterinary purposes; impregnated medicated wipes; medicinal preparations and substances, namely, for the treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; reagents for microbiological analysis for veterinary purposes; impregnated medicated swabs; diagnostic reagents for medical use; enzymes for veterinary purposes; reagents for microbiological analysis for medical purposes; reagent paper for medical purposes; reagent paper for veterinary purposes; capillary stabilizing agents for medical purposes; diagnostic agents for medical use; wadding for medical purposes; dental preparations for disclosing plaque | ACTIVE | — |
| 010 | Insulin syringes sold empty; genetic testing apparatus for medical purposes; diagnostic testing instruments for use in immunoassay procedure for medical use; testing apparatus for medical purposes, namely, genetic testing apparatus for medical purposes, DNA and RNA testing apparatus for medical purposes, medical diagnostic apparatus for testing for blood analysis, plasma analysis, serum analysis, blood component analysis, feces analysis, urine analysis, tissue analysis, tissue fliud analysis, body secretion analysis; membrane test plates for use in medical diagnostics; medical test kits for diabetes monitoring for home use; test probes for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus, nuclear medical diagnostic imaging apparatus, medical apparatus for diagnostic radiopharmaceutical use, organoleptic diagnostic testing apparatus; diagnostic testing instruments for use in immunoassay procedure for medical purposes; testing apparatus for medical purposes, namely, for immunochemical tesing, diagnostic apparatus for testing for viruses or bacteria, genetic testing apparatus, apparatus for DAN and RNA testing for medical purposes; medical apparatus and instruments, namely, medical radiation apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, electromagnetic drug delivery apparatus for medical use, medical instruments for cutting tissues, medical instruments for examing women's reproductive organs, medical instruments for use in general surgery, medical instruments for use in performing biopsies; medical apparatus for testing the level of glucose in the blood; chromatographic apparatus for medical purposes; medical diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; measuring devices for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; chromatographic devices for medical purposes; measuring instruments adapted for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; tongue depressors for medical purposes; apparatus for analysing substances, namely, body fluids, blood, body tissues, bacterial cultures, mucous for medical use; medical therapy instruments, namely, implantable radiation therapy devices consisting of radioactive seeds, medical devices for moxibustion therapy, a device for improving cardiac performance through aortic flow therapy; blood collection tubes for medical use; chromatographic columns for medical use; medical diagnostic saliva vials; blood group analyzers for medical use; fibrescopes for medical use; chromatogram analyzers for medical use; medical analytical apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; automated analyzers for foreign matter contained in body fluids for medical use; chromatographic instruments for medical use; medical apparatus for diagnosing suspected heart attacks; diagnostic measuring apparatus for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices meauring tumors; diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; apparatus for DNA and RNA testing for medical purposes; electronic apparatus for medical purposes, namely, electronic medical appliances for wound healing, electronic temperature monitors, electronic muscle stimulators, EKG machines, medical apparatus for monitoring vital signs, blood property and respiratory events; chromatography plates for medical use; chromatographic instruments for medical purposes; body composition analyzers for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Rainer Böhnke
- Other trademarks owned by Rainer Böhnke
- Other trademarks owned by PharmACT Holding AG
- Other trademarks owned by PharmACT Holding AG
- Other trademarks owned by PharmACT Holding AG
- Other trademarks owned by Rainer Böhnke
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BELTEST-IT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 13, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 13, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 5, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 13, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 11, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 2, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 2, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 2, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 2, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 14, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 14, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 13, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 12, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |